Dastmalchian, Sara
Kilinc, Ozden
Onyewadume, Louisa
Tippareddy, Charit
McGivney, Debra
Ma, Dan
Griswold, Mark
Sunshine, Jeffrey
Gulani, Vikas
Barnholtz-Sloan, Jill S.
Sloan, Andrew E.
Badve, Chaitra http://orcid.org/0000-0001-8547-8019
Funding for this research was provided by:
Siemens Healthineers (Institutional research support)
National Institutes of Health (1R01BB017219, 1R01EB016728, CA217956)
National Center for Advancing Translational Sciences (UL1TR002548)
Article History
Received: 21 May 2020
Accepted: 11 September 2020
First Online: 26 September 2020
Compliance with ethical standards
:
: Case Western Reserve University and University Hospitals receive research support from Siemens. Chaitra Badve, Dan Ma, Andrew E. Sloan, Jeffrey Sunshine, Mark Griswold, and Vikas Gulani have patent applications on MRF applications in brain tumors.Sara Dastmalchian, Ozden Kilinc, Louisa Onyewadume, Charit Tippareddy, Debra McGivney, Jill Barnholtz-Sloan do not have any relevant conflicts of interest to disclose.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
: Not applicable.
: NA